APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Diagnostic Imaging Agent

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Diagnostic Imaging Agent Market Outlook and Growth Opportunities 2026

Report ID 173902880426 December 2025197 pages

Choose your research edition.

Industry ResearchDiagnostic Imaging Agent Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Diagnostic Imaging Agent Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Diagnostic Imaging Agent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Diagnostic Imaging Agent Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Diagnostic Imaging Agent Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Diagnostic Imaging Agent market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Diagnostic Imaging Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Diagnostic Imaging Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Diagnostic Imaging Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Diagnostic Imaging Agent market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Diagnostic Imaging Agent market include GE HealthCare, Bracco Diagnostic, Guerbet, Abx Advanced Biochemical, Bayer AG, Blue Earth Diagnostics, Cardinal Health, Eli Lilly and Company and Lantheus, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Diagnostic Imaging Agent market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Diagnostic Imaging Agent and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Diagnostic Imaging Agent sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Diagnostic Imaging Agent market size, projected growth trends, production technologies, key applications, and end-use industries.

Diagnostic Imaging Agent Segment by Company

GE HealthCare

Bracco Diagnostic

Guerbet

Abx Advanced Biochemical

Bayer AG

Blue Earth Diagnostics

Cardinal Health

Eli Lilly and Company

Lantheus

Mallinckrodt

Navidea

Yantai Dongcheng

Foshan Rui Diao Pharmaceutical

Jubilant Pharma Limited

Diagnostic Imaging Agent Segment by Type

Conjugated Imaging Agent

Metabolic Imaging Agent

Blood Flow and Blood Volume Imaging Agents

Diagnostic Imaging Agent Segment by Application

Neurological Disease

Gastrointestinal Disease

Heart Disease

Tumor

Diagnostic Imaging Agent Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Diagnostic Imaging Agent status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Diagnostic Imaging Agent market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Diagnostic Imaging Agent significant trends, drivers, influence factors in global and regions.

6. To analyze Diagnostic Imaging Agent competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diagnostic Imaging Agent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Diagnostic Imaging Agent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diagnostic Imaging Agent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Diagnostic Imaging Agent market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Diagnostic Imaging Agent industry.

Chapter 3: Detailed analysis of Diagnostic Imaging Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Diagnostic Imaging Agent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Diagnostic Imaging Agent in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Diagnostic Imaging Agent Industry Trends Table 2. Diagnostic Imaging Agent Industry Drivers Table 3. Diagnostic Imaging Agent Industry Opportunities and Challenges Table 4. Diagnostic Imaging Agent Industry Restraints Table 5. Global Diagnostic Imaging Agent Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Diagnostic Imaging Agent Revenue Share by Company (2021-2026) Table 7. Global Diagnostic Imaging Agent Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Diagnostic Imaging Agent Sales Volume Share by Company (2021-2026) Table 9. Global Diagnostic Imaging Agent Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Diagnostic Imaging Agent Company Ranking, (2024-2026) & (USD Million) Table 11. Global Diagnostic Imaging Agent Key Company Manufacturing Base & Headquarters Table 12. Global Diagnostic Imaging Agent Company, Product Type & Application Table 13. Global Diagnostic Imaging Agent Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Diagnostic Imaging Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Conjugated Imaging Agent Table 18. Significant Companies of Metabolic Imaging Agent Table 19. Significant Companies of Blood Flow and Blood Volume Imaging Agents Table 20. Global Diagnostic Imaging Agent Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Diagnostic Imaging Agent Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Diagnostic Imaging Agent Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Diagnostic Imaging Agent Sales Volume Share by Type (2021-2026) Table 24. Global Diagnostic Imaging Agent Sales Volume Share by Type (2027-2032) Table 25. Global Diagnostic Imaging Agent Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Diagnostic Imaging Agent Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Diagnostic Imaging Agent Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Diagnostic Imaging Agent Sales Value Share by Type (2021-2026) Table 29. Global Diagnostic Imaging Agent Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Neurological Disease Table 31. Significant Companies of Gastrointestinal Disease Table 32. Significant Companies of Heart Disease Table 33. Significant Companies of Tumor Table 34. Global Diagnostic Imaging Agent Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Diagnostic Imaging Agent Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Diagnostic Imaging Agent Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Diagnostic Imaging Agent Sales Volume Share by Application (2021-2026) Table 38. Global Diagnostic Imaging Agent Sales Volume Share by Application (2027-2032) Table 39. Global Diagnostic Imaging Agent Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Diagnostic Imaging Agent Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Diagnostic Imaging Agent Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Diagnostic Imaging Agent Sales Value Share by Application (2021-2026) Table 43. Global Diagnostic Imaging Agent Sales Value Share by Application (2027-2032) Table 44. Global Diagnostic Imaging Agent Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Diagnostic Imaging Agent Sales by Region (2021-2026) & (K Units) Table 46. Global Diagnostic Imaging Agent Sales Market Share by Region (2021-2026) Table 47. Global Diagnostic Imaging Agent Sales by Region (2027-2032) & (K Units) Table 48. Global Diagnostic Imaging Agent Sales Market Share by Region (2027-2032) Table 49. Global Diagnostic Imaging Agent Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Diagnostic Imaging Agent Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Diagnostic Imaging Agent Sales Value Share by Region (2021-2026) Table 52. Global Diagnostic Imaging Agent Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Diagnostic Imaging Agent Sales Value Share by Region (2027-2032) Table 54. Global Diagnostic Imaging Agent Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Diagnostic Imaging Agent Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Diagnostic Imaging Agent Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Diagnostic Imaging Agent Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Diagnostic Imaging Agent Sales by Country (2021-2026) & (K Units) Table 59. Global Diagnostic Imaging Agent Sales Market Share by Country (2021-2026) Table 60. Global Diagnostic Imaging Agent Sales by Country (2027-2032) & (K Units) Table 61. Global Diagnostic Imaging Agent Sales Market Share by Country (2027-2032) Table 62. Global Diagnostic Imaging Agent Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Diagnostic Imaging Agent Sales Value Market Share by Country (2021-2026) Table 64. Global Diagnostic Imaging Agent Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Diagnostic Imaging Agent Sales Value Market Share by Country (2027-2032) Table 66. GE HealthCare Company Information Table 67. GE HealthCare Business Overview Table 68. GE HealthCare Diagnostic Imaging Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. GE HealthCare Diagnostic Imaging Agent Product Portfolio Table 70. GE HealthCare Recent Development Table 71. Bracco Diagnostic Company Information Table 72. Bracco Diagnostic Business Overview Table 73. Bracco Diagnostic Diagnostic Imaging Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Bracco Diagnostic Diagnostic Imaging Agent Product Portfolio Table 75. Bracco Diagnostic Recent Development Table 76. Guerbet Company Information Table 77. Guerbet Business Overview Table 78. Guerbet Diagnostic Imaging Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Guerbet Diagnostic Imaging Agent Product Portfolio Table 80. Guerbet Recent Development Table 81. Abx Advanced Biochemical Company Information Table 82. Abx Advanced Biochemical Business Overview Table 83. Abx Advanced Biochemical Diagnostic Imaging Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Abx Advanced Biochemical Diagnostic Imaging Agent Product Portfolio Table 85. Abx Advanced Biochemical Recent Development Table 86. Bayer AG Company Information Table 87. Bayer AG Business Overview Table 88. Bayer AG Diagnostic Imaging Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Bayer AG Diagnostic Imaging Agent Product Portfolio Table 90. Bayer AG Recent Development Table 91. Blue Earth Diagnostics Company Information Table 92. Blue Earth Diagnostics Business Overview Table 93. Blue Earth Diagnostics Diagnostic Imaging Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Blue Earth Diagnostics Diagnostic Imaging Agent Product Portfolio Table 95. Blue Earth Diagnostics Recent Development Table 96. Cardinal Health Company Information Table 97. Cardinal Health Business Overview Table 98. Cardinal Health Diagnostic Imaging Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Cardinal Health Diagnostic Imaging Agent Product Portfolio Table 100. Cardinal Health Recent Development Table 101. Eli Lilly and Company Company Information Table 102. Eli Lilly and Company Business Overview Table 103. Eli Lilly and Company Diagnostic Imaging Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Eli Lilly and Company Diagnostic Imaging Agent Product Portfolio Table 105. Eli Lilly and Company Recent Development Table 106. Lantheus Company Information Table 107. Lantheus Business Overview Table 108. Lantheus Diagnostic Imaging Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Lantheus Diagnostic Imaging Agent Product Portfolio Table 110. Lantheus Recent Development Table 111. Mallinckrodt Company Information Table 112. Mallinckrodt Business Overview Table 113. Mallinckrodt Diagnostic Imaging Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Mallinckrodt Diagnostic Imaging Agent Product Portfolio Table 115. Mallinckrodt Recent Development Table 116. Navidea Company Information Table 117. Navidea Business Overview Table 118. Navidea Diagnostic Imaging Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Navidea Diagnostic Imaging Agent Product Portfolio Table 120. Navidea Recent Development Table 121. Yantai Dongcheng Company Information Table 122. Yantai Dongcheng Business Overview Table 123. Yantai Dongcheng Diagnostic Imaging Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Yantai Dongcheng Diagnostic Imaging Agent Product Portfolio Table 125. Yantai Dongcheng Recent Development Table 126. Foshan Rui Diao Pharmaceutical Company Information Table 127. Foshan Rui Diao Pharmaceutical Business Overview Table 128. Foshan Rui Diao Pharmaceutical Diagnostic Imaging Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Foshan Rui Diao Pharmaceutical Diagnostic Imaging Agent Product Portfolio Table 130. Foshan Rui Diao Pharmaceutical Recent Development Table 131. Jubilant Pharma Limited Company Information Table 132. Jubilant Pharma Limited Business Overview Table 133. Jubilant Pharma Limited Diagnostic Imaging Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Jubilant Pharma Limited Diagnostic Imaging Agent Product Portfolio Table 135. Jubilant Pharma Limited Recent Development Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Diagnostic Imaging Agent Distributors List Table 139. Diagnostic Imaging Agent Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Diagnostic Imaging Agent Product Image Figure 2. Global Diagnostic Imaging Agent Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Diagnostic Imaging Agent Sales Value (2021-2032) & (US$ Million) Figure 4. Global Diagnostic Imaging Agent Sales (2021-2032) & (K Units) Figure 5. Global Diagnostic Imaging Agent Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Diagnostic Imaging Agent Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Conjugated Imaging Agent Image Figure 10. Metabolic Imaging Agent Image Figure 11. Blood Flow and Blood Volume Imaging Agents Image Figure 12. Global Diagnostic Imaging Agent Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Diagnostic Imaging Agent Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Diagnostic Imaging Agent Sales Volume Share by Type (2021-2032) Figure 15. Global Diagnostic Imaging Agent Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Diagnostic Imaging Agent Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Diagnostic Imaging Agent Sales Value Share by Type (2021-2032) Figure 18. Neurological Disease Image Figure 19. Gastrointestinal Disease Image Figure 20. Heart Disease Image Figure 21. Tumor Image Figure 22. Global Diagnostic Imaging Agent Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Diagnostic Imaging Agent Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Diagnostic Imaging Agent Sales Volume Share by Application (2021-2032) Figure 25. Global Diagnostic Imaging Agent Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Diagnostic Imaging Agent Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Diagnostic Imaging Agent Sales Value Share by Application (2021-2032) Figure 28. Global Diagnostic Imaging Agent Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Diagnostic Imaging Agent Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Diagnostic Imaging Agent Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Diagnostic Imaging Agent Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Diagnostic Imaging Agent Sales Value (2021-2032) & (US$ Million) Figure 33. North America Diagnostic Imaging Agent Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Diagnostic Imaging Agent Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Diagnostic Imaging Agent Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Diagnostic Imaging Agent Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Diagnostic Imaging Agent Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Diagnostic Imaging Agent Sales Value (2021-2032) & (US$ Million) Figure 39. South America Diagnostic Imaging Agent Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Diagnostic Imaging Agent Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Diagnostic Imaging Agent Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Diagnostic Imaging Agent Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Diagnostic Imaging Agent Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Conjugated Imaging Agent
  • Metabolic Imaging Agent
  • Blood Flow and Blood Volume Imaging Agents
Applications
  • Neurological Disease
  • Gastrointestinal Disease
  • Heart Disease
  • Tumor
Companies covered
  • GE HealthCare
  • Bracco Diagnostic
  • Guerbet
  • Abx Advanced Biochemical
  • Bayer AG
  • Blue Earth Diagnostics
  • Cardinal Health
  • Eli Lilly and Company
  • Lantheus
  • Mallinckrodt
  • Navidea
  • Yantai Dongcheng
  • Foshan Rui Diao Pharmaceutical
  • Jubilant Pharma Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Diagnostic Imaging Agent Sales Value (2021-2032)
  4. 1.2.2 Global Diagnostic Imaging Agent Sales Volume (2021-2032)
  5. 1.2.3 Global Diagnostic Imaging Agent Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Diagnostic Imaging Agent Market Dynamics
  1. 2.1 Diagnostic Imaging Agent Industry Trends
  2. 2.2 Diagnostic Imaging Agent Industry Drivers
  3. 2.3 Diagnostic Imaging Agent Industry Opportunities and Challenges
  4. 2.4 Diagnostic Imaging Agent Industry Restraints
3 Diagnostic Imaging Agent Market by Company
  1. 3.1 Global Diagnostic Imaging Agent Company Revenue Ranking in 2025
  2. 3.2 Global Diagnostic Imaging Agent Revenue by Company (2021-2026)
  3. 3.3 Global Diagnostic Imaging Agent Sales Volume by Company (2021-2026)
  4. 3.4 Global Diagnostic Imaging Agent Average Price by Company (2021-2026)
  5. 3.5 Global Diagnostic Imaging Agent Company Ranking (2024-2026)
  6. 3.6 Global Diagnostic Imaging Agent Company Manufacturing Base and Headquarters
  7. 3.7 Global Diagnostic Imaging Agent Company Product Type and Application
  8. 3.8 Global Diagnostic Imaging Agent Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Diagnostic Imaging Agent Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Diagnostic Imaging Agent Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Diagnostic Imaging Agent Market by Type
  1. 4.1 Diagnostic Imaging Agent Type Introduction
  2. 4.1.1 Conjugated Imaging Agent
  3. 4.1.2 Metabolic Imaging Agent
  4. 4.1.3 Blood Flow and Blood Volume Imaging Agents
  5. 4.2 Global Diagnostic Imaging Agent Sales Volume by Type
  6. 4.2.1 Global Diagnostic Imaging Agent Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Diagnostic Imaging Agent Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Diagnostic Imaging Agent Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Diagnostic Imaging Agent Sales Value by Type
  10. 4.3.1 Global Diagnostic Imaging Agent Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Diagnostic Imaging Agent Sales Value by Type (2021-2032)
  12. 4.3.3 Global Diagnostic Imaging Agent Sales Value Share by Type (2021-2032)
5 Diagnostic Imaging Agent Market by Application
  1. 5.1 Diagnostic Imaging Agent Application Introduction
  2. 5.1.1 Neurological Disease
  3. 5.1.2 Gastrointestinal Disease
  4. 5.1.3 Heart Disease
  5. 5.1.4 Tumor
  6. 5.2 Global Diagnostic Imaging Agent Sales Volume by Application
  7. 5.2.1 Global Diagnostic Imaging Agent Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Diagnostic Imaging Agent Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Diagnostic Imaging Agent Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Diagnostic Imaging Agent Sales Value by Application
  11. 5.3.1 Global Diagnostic Imaging Agent Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Diagnostic Imaging Agent Sales Value by Application (2021-2032)
  13. 5.3.3 Global Diagnostic Imaging Agent Sales Value Share by Application (2021-2032)
6 Diagnostic Imaging Agent Regional Sales and Value Analysis
  1. 6.1 Global Diagnostic Imaging Agent Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Diagnostic Imaging Agent Sales by Region (2021-2032)
  3. 6.2.1 Global Diagnostic Imaging Agent Sales by Region: 2021-2026
  4. 6.2.2 Global Diagnostic Imaging Agent Sales by Region (2027-2032)
  5. 6.3 Global Diagnostic Imaging Agent Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Diagnostic Imaging Agent Sales Value by Region (2021-2032)
  7. 6.4.1 Global Diagnostic Imaging Agent Sales Value by Region: 2021-2026
  8. 6.4.2 Global Diagnostic Imaging Agent Sales Value by Region (2027-2032)
  9. 6.5 Global Diagnostic Imaging Agent Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Diagnostic Imaging Agent Sales Value (2021-2032)
  12. 6.6.2 North America Diagnostic Imaging Agent Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Diagnostic Imaging Agent Sales Value (2021-2032)
  15. 6.7.2 Europe Diagnostic Imaging Agent Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Diagnostic Imaging Agent Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Diagnostic Imaging Agent Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Diagnostic Imaging Agent Sales Value (2021-2032)
  21. 6.9.2 South America Diagnostic Imaging Agent Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Diagnostic Imaging Agent Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Diagnostic Imaging Agent Sales Value Share by Country, 2025 VS 2032
7 Diagnostic Imaging Agent Country-level Sales and Value Analysis
  1. 7.1 Global Diagnostic Imaging Agent Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Diagnostic Imaging Agent Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Diagnostic Imaging Agent Sales by Country (2021-2032)
  4. 7.3.1 Global Diagnostic Imaging Agent Sales by Country (2021-2026)
  5. 7.3.2 Global Diagnostic Imaging Agent Sales by Country (2027-2032)
  6. 7.4 Global Diagnostic Imaging Agent Sales Value by Country (2021-2032)
  7. 7.4.1 Global Diagnostic Imaging Agent Sales Value by Country (2021-2026)
  8. 7.4.2 Global Diagnostic Imaging Agent Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Diagnostic Imaging Agent Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Diagnostic Imaging Agent Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Diagnostic Imaging Agent Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GE HealthCare
  2. 8.1.1 GE HealthCare Company Information
  3. 8.1.2 GE HealthCare Business Overview
  4. 8.1.3 GE HealthCare Diagnostic Imaging Agent Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 GE HealthCare Diagnostic Imaging Agent Product Portfolio
  6. 8.1.5 GE HealthCare Recent Developments
  7. 8.2 Bracco Diagnostic
  8. 8.2.1 Bracco Diagnostic Company Information
  9. 8.2.2 Bracco Diagnostic Business Overview
  10. 8.2.3 Bracco Diagnostic Diagnostic Imaging Agent Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bracco Diagnostic Diagnostic Imaging Agent Product Portfolio
  12. 8.2.5 Bracco Diagnostic Recent Developments
  13. 8.3 Guerbet
  14. 8.3.1 Guerbet Company Information
  15. 8.3.2 Guerbet Business Overview
  16. 8.3.3 Guerbet Diagnostic Imaging Agent Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Guerbet Diagnostic Imaging Agent Product Portfolio
  18. 8.3.5 Guerbet Recent Developments
  19. 8.4 Abx Advanced Biochemical
  20. 8.4.1 Abx Advanced Biochemical Company Information
  21. 8.4.2 Abx Advanced Biochemical Business Overview
  22. 8.4.3 Abx Advanced Biochemical Diagnostic Imaging Agent Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Abx Advanced Biochemical Diagnostic Imaging Agent Product Portfolio
  24. 8.4.5 Abx Advanced Biochemical Recent Developments
  25. 8.5 Bayer AG
  26. 8.5.1 Bayer AG Company Information
  27. 8.5.2 Bayer AG Business Overview
  28. 8.5.3 Bayer AG Diagnostic Imaging Agent Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Bayer AG Diagnostic Imaging Agent Product Portfolio
  30. 8.5.5 Bayer AG Recent Developments
  31. 8.6 Blue Earth Diagnostics
  32. 8.6.1 Blue Earth Diagnostics Company Information
  33. 8.6.2 Blue Earth Diagnostics Business Overview
  34. 8.6.3 Blue Earth Diagnostics Diagnostic Imaging Agent Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Blue Earth Diagnostics Diagnostic Imaging Agent Product Portfolio
  36. 8.6.5 Blue Earth Diagnostics Recent Developments
  37. 8.7 Cardinal Health
  38. 8.7.1 Cardinal Health Company Information
  39. 8.7.2 Cardinal Health Business Overview
  40. 8.7.3 Cardinal Health Diagnostic Imaging Agent Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Cardinal Health Diagnostic Imaging Agent Product Portfolio
  42. 8.7.5 Cardinal Health Recent Developments
  43. 8.8 Eli Lilly and Company
  44. 8.8.1 Eli Lilly and Company Company Information
  45. 8.8.2 Eli Lilly and Company Business Overview
  46. 8.8.3 Eli Lilly and Company Diagnostic Imaging Agent Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Eli Lilly and Company Diagnostic Imaging Agent Product Portfolio
  48. 8.8.5 Eli Lilly and Company Recent Developments
  49. 8.9 Lantheus
  50. 8.9.1 Lantheus Company Information
  51. 8.9.2 Lantheus Business Overview
  52. 8.9.3 Lantheus Diagnostic Imaging Agent Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Lantheus Diagnostic Imaging Agent Product Portfolio
  54. 8.9.5 Lantheus Recent Developments
  55. 8.10 Mallinckrodt
  56. 8.10.1 Mallinckrodt Company Information
  57. 8.10.2 Mallinckrodt Business Overview
  58. 8.10.3 Mallinckrodt Diagnostic Imaging Agent Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Mallinckrodt Diagnostic Imaging Agent Product Portfolio
  60. 8.10.5 Mallinckrodt Recent Developments
  61. 8.11 Navidea
  62. 8.11.1 Navidea Company Information
  63. 8.11.2 Navidea Business Overview
  64. 8.11.3 Navidea Diagnostic Imaging Agent Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Navidea Diagnostic Imaging Agent Product Portfolio
  66. 8.11.5 Navidea Recent Developments
  67. 8.12 Yantai Dongcheng
  68. 8.12.1 Yantai Dongcheng Company Information
  69. 8.12.2 Yantai Dongcheng Business Overview
  70. 8.12.3 Yantai Dongcheng Diagnostic Imaging Agent Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Yantai Dongcheng Diagnostic Imaging Agent Product Portfolio
  72. 8.12.5 Yantai Dongcheng Recent Developments
  73. 8.13 Foshan Rui Diao Pharmaceutical
  74. 8.13.1 Foshan Rui Diao Pharmaceutical Company Information
  75. 8.13.2 Foshan Rui Diao Pharmaceutical Business Overview
  76. 8.13.3 Foshan Rui Diao Pharmaceutical Diagnostic Imaging Agent Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Foshan Rui Diao Pharmaceutical Diagnostic Imaging Agent Product Portfolio
  78. 8.13.5 Foshan Rui Diao Pharmaceutical Recent Developments
  79. 8.14 Jubilant Pharma Limited
  80. 8.14.1 Jubilant Pharma Limited Company Information
  81. 8.14.2 Jubilant Pharma Limited Business Overview
  82. 8.14.3 Jubilant Pharma Limited Diagnostic Imaging Agent Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Jubilant Pharma Limited Diagnostic Imaging Agent Product Portfolio
  84. 8.14.5 Jubilant Pharma Limited Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Diagnostic Imaging Agent Value Chain Analysis
  2. 9.1.1 Diagnostic Imaging Agent Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Diagnostic Imaging Agent Sales Mode & Process
  6. 9.2 Diagnostic Imaging Agent Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Diagnostic Imaging Agent Distributors
  9. 9.2.3 Diagnostic Imaging Agent Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst